UWE.TO Stock News U3O8 Corp (UWE.TO) 0.10 08/01/2014 06:35:2

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
U3O8 Corp (UWE.TO) 0.10 $UWE.TO

U3O8 Corp. Shareholders Approved All Matters at Annual & Special Meeting
Marketwire - Wed Jun 25, 7:31AM CDT
U3O8 Corp. (TSX: UWE) (OTCQX: UWEFF), a Canadian-based company focused on exploration and resource expansion of uranium and associated commodities in South America, reported that the nominees listed in its Management Information Circular were elected as directors of the company at its Annual and Special Meeting held on June 24, 2014. In addition, KPMG LLP was re-appointed as U3O8 Corp's auditors, and its Shareholders Rights Plan was approved. The detailed results of the management proxy votes received for each director were as follows:

U3O8 Corp. Spins Out Its Carina Property in Argentina Into a Frac Sand Focused Company to Maximize Opportunity
Marketwire - Thu May 29, 5:46AM CDT
U3O8 Corp. (TSX: UWE)(OTCQX: UWEFF), a Canadian-based company focused on exploration and development of uranium resources and associated commodities in South America, has vended its 100% interest in the Carina property in Chubut Province, Argentina (Figure 1) to South American Rare Earth Corp. ("SAREC", a private investee company of U3O8 Corp. As consideration for Carina, U3O8 Corp. increases its ownership in SAREC from 13% to 39% as well as retaining a 7.5% net smelter royalty ("NSR" on frac sand production from the property. The Carina concession is prospective for frac sand for potential use in the extraction of oil and gas from shale.

U3O8 Corp.Signs Agreement for Near-Term Production Potential of Frac Sand from Its Carina Property in Argentina
Marketwire - Thu Jan 16, 5:46AM CST
U3O8 Corp. (TSX: UWE) (OTCQX: UWEFF), a Canadian-based company focused on exploration and development of uranium resources and associated commodities in South America, has granted rights to a 100 hectare ("Ha" area of its Carina property in Chubut Province, Argentina (Figure 1) to an Argentine operator for which U3O8 Corp. will receive annual cash option payments and a 7.5% gross royalty on production ("NSR". The Carina property contains silica sand for potential use in the production of oil and gas from shale.

U3O8 Corp. & Chubut Provincial Government in Advanced Negotiations to Partner on the Laguna Salada Project in Argentina
Marketwire - Tue Aug 27, 5:46AM CDT
U3O8 Corp. (TSX: UWE)(OTCQX: UWEFF), a Canadian-based company focused on exploration and resource expansion of uranium and associated commodities in South America, is in advanced discussions to enter into a joint venture with Petrominera Chubut S.E. ("Petrominera", the provincial mining company of Chubut Province, Argentina. The proposed partnership would bring together U3O8 Corp's Laguna Salada Project and adjoining Petrominera concessions for further exploration, resource growth and establish a framework for potential development of the Laguna Salada Deposit in compliance with the stringent requirements of the current provincial mining law.

U3O8 Corp. Advancing Strategy for Near-Term Development to Meet Argentina's Growing Need for Domestic Uranium Supply
Marketwire - Thu May 16, 10:59AM CDT
U3O8 Corp. (TSX: UWE)(OTCQX: UWEFF), a Canadian-based company focused on exploration and resource expansion of uranium and associated commodities in South America, outlines its growth strategy in Argentina, which aims to position U3O8 Corp's Laguna Salada Deposit, defined in accordance with National Instrument 43-101 ("NI 43-101", as a potential low-cost, near-term producer while setting up a pipeline of projects for sequential exploration.

U3O8 Corp. Completes Acquisition of Calypso Uranium Corp.
Marketwire - Tue May 14, 1:20PM CDT
U3O8 Corp. (TSX: UWE)(OTCQX: UWEFF) and Calypso Uranium Corp. (TSX VENTURE: CLP) ("Calypso" are pleased to announce the completion of the acquisition of Calypso by U3O8 Corp. (the "Acquisition". The Acquisition expands U3O8 Corp's strategic land position around the state-owned Cerro Solo and Sierra Pintada uranium deposits in Argentina and adds approximately $3.3 million in working capital.

U3O8 Corp. Adopts Advance Notice By-Law
Marketwire - Mon May 13, 3:35PM CDT
U3O8 Corp. (TSX: UWE)(OTCQX: UWEFF), a Canadian-based company focused on exploration and resource expansion of uranium and associated commodities in South America, has adopted a new by-law that requires advance notice to U3O8 Corp. when director nominations are made by shareholders other than through a requisition for a meeting or shareholder proposal, in each case in accordance with the Business Corporation Act (Ontario).

U3O8 Corp's Acquisition of Calypso Uranium Corp. Receives Shareholder Approval
Marketwire - Wed May 08, 4:24PM CDT
U3O8 Corp. (TSX: UWE)(OTCQX: UWEFF), a Canadian-based company focused on exploration and resource expansion of uranium and associated commodities in South America, is pleased to report that shareholders of Calypso Uranium Corp. ("Calypso" have approved the acquisition of Calypso by U3O8 Corp. The transaction is subject to final regulatory and court approvals. The acquisition will expand U3O8 Corp's strategic land position around the state-owned Cerro Solo and Sierra Pintada uranium deposits in Argentina and adds about $3.3 million in cash.

Calypso Shareholders Approve Acquisition by U3O8 Corp.
Marketwire - Wed May 08, 4:15PM CDT
Calypso Uranium Corp. ("Calypso" or the "Company" (TSX VENTURE: CLP) is pleased to announce that the acquisition of Calypso by U3O8 Corp. (TSX: UWE) ("U3O8 Corp." was approved at Calypso's annual general and special meeting of shareholders today. The acquisition of Calypso by U3O8 Corp. through a court-approved plan of arrangement (the "Arrangement" under the Business Corporations Act, British Columbia, was announced on March 11, 2013. Under the terms of the Arrangement, each Calypso Share will be exchanged for 0.40 of one common share in the capital of U3O8 Corp.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 255

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 266

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 185

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 176

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading
Viking Ventures: Impacts of VK2735 on Obesity Examined

Updated Category News Views 210

Viking Therapeutics Reveal Surprising Data on VK2735 The latest from Viking Therapeutics' camp is giving obesity some serious food for thought, with new data making waves at the ObesityWeek® 2026 meeting. Their investigational dual agonist, VK2735, seems to be shaking things up, as early phase clinical data shows an impressive 74% of participants managed to improve at...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 113

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 251

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading
YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 115

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 119

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 59

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading

Top 5 Most Recently Viewed Articles

Innovative Scent Dispensing Solution for Hunting Enthusiasts

Updated Category News Views 168

Introducing a Game-Changing Scent Dispensing System In the world of hunting, attracting game animals can often be a challenge. A new invention, designed specifically for this purpose, promises to make the process much simpler and more efficient. The inventor of this innovative scent dispensing system, THE DRAG LINE PRO, envisioned a better way to utilize a scent drag...

Continue Reading
Corby Spirit and Wine Limited Reports Impressive Fiscal Results

Updated Category News Views 295

Corby Spirit and Wine Limited Announces Strong Fiscal Performance Corby Spirit and Wine Limited, renowned for its position as a leading Canadian manufacturer, marketer, and importer of spirits, has recently unveiled impressive results for its fourth quarter and full-year fiscal 2025. The company demonstrated significant growth in revenue, achieving total revenues of...

Continue Reading
Sezzle Faces Setback as Short-Seller Targets Its Practices

Updated Category News Views 113

Sezzle's Stock Takes a Dramatic Hit Recently, the buy now, pay later (BNPL) provider Sezzle experienced a significant decrease in its stock value. Reports indicate that shares fell over 28.6% in early trading after Hindenburg Research disclosed a short position against the company due to concerns surrounding risky lending practices. Understanding the Short-Selling...

Continue Reading
Exploring the Growth of $1000 in Marsh & McLennan Cos Today

Updated Category News Views 116

Understanding Long-Term Investment in Marsh & McLennan Marsh & McLennan Cos (NYSE: MMC) has established itself as a financial powerhouse, outperforming the market consistently over the past two decades. Investors have experienced an impressive annualized return of 13.31%, showcasing the benefits of long-term investment strategies. The Value of Persistence in Investing...

Continue Reading
Discover Toll Brothers' Latest Luxury Homes at Overbrook Estates

Updated Category News Views 671

Introducing Overbrook Estates by Toll Brothers Toll Brothers, Inc. (NYSE:TOL), a renowned name in luxury homebuilding, excitedly unveils its newest community: Overbrook Estates. This anticipated project is set to grace the Huntersville area, offering homebuyers elegant living in a master-planned environment. Positioned conveniently off Highway 77, this prime location sets...

Continue Reading